<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08906092200156</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>EYEVISC</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EYEVISC</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:44:08.602Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200118</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>08906092200118</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EYEVISC PFS 2.4%</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:44:06.884Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200675</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>08906092200675</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>METILON 20 PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:44:06.141Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200187</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200187</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:52.405Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200170</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200170</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR PLUS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:35.105Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200071</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200071</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR HV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:34.010Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200057</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200057</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR EV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:19.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200255</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200255</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR SV</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:17.110Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200408</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200408</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:43:03.906Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200415</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200415</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:42:50.199Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200422</udiDi>
    <basicUdiDi>890609220HAOSGV</basicUdiDi>
    <tradeName>08906092200422</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BIO-HYALUR DUO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:41:10.320Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906092200798</udiDi>
    <basicUdiDi>890609220HPMCJ2</basicUdiDi>
    <tradeName>08906092200798</tradeName>
    <deviceName></deviceName>
    <manufacturerName>BIO-TECH VISION CARE PVT. LTD.</manufacturerName>
    <manufacturerSrn>IN-MF-000008482</manufacturerSrn>
    <authorisedRepresentativeName>Biotech Europe Meditech Inc Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000004696</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OPTICEL PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:40:05.282Z</lastUpdated>
  </row>
  <row>
    <udiDi>06936020103046</udiDi>
    <basicUdiDi>69360201088U</basicUdiDi>
    <tradeName>Singclean®</tradeName>
    <deviceName>Viscoelastic Solution for Ophthalmic Surgery</deviceName>
    <manufacturerName>Hangzhou Singclean Medical Products Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000014098</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OPH-SC-15-0.5</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-02T07:04:39.398Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532970</udiDi>
    <basicUdiDi>426059553MP03UD01JE</basicUdiDi>
    <tradeName>BLUpan® medical UD</tradeName>
    <deviceName>Sodium Hyaluronate - Dexpanthenol Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41127200</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:34.840Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532697</udiDi>
    <basicUdiDi>426059553MP44OSD012E</basicUdiDi>
    <tradeName>Visiodoron Malva® Intense</tradeName>
    <deviceName>Sodium Hyaluronate 0.3% - Malva Sylvestris Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41125400</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:33.234Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532192</udiDi>
    <basicUdiDi>426059553MP18OSD012F</basicUdiDi>
    <tradeName>Visiodoron Malva®</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% - Malva Sylvestris Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41112900</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:30.036Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595532147</udiDi>
    <basicUdiDi>426059553MP18UD01LJ</basicUdiDi>
    <tradeName>Visiodoron Malva® (Muster)</tradeName>
    <deviceName>Sodium Hyaluronate 0.15% - Malva Sylvestris Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41100700</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:28.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595531492</udiDi>
    <basicUdiDi>426059553MP27OSD012K</basicUdiDi>
    <tradeName>HYDRO med Blue</tradeName>
    <deviceName>Sodium Hyaluronate - Patent Blue V Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41117200</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:18.920Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530976</udiDi>
    <basicUdiDi>426059553MP02UD01J3</basicUdiDi>
    <tradeName>BIOLAN® gel (Muster)</tradeName>
    <deviceName>Sodium Hyaluronate 0.3% Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41019200</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:15.748Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530907</udiDi>
    <basicUdiDi>426059553MP25UD01KW</basicUdiDi>
    <tradeName>EyeMedica® Euphrasia Augentrost Augen-Tropfen SOS</tradeName>
    <deviceName>Sodium Hyaluronate - Euphrasia Eye Drops</deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41128000</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:53:14.157Z</lastUpdated>
  </row>
</eudamedExport>